RPS29P23

Across TCGA pan-cancer cohorts, RPS29P23 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPS29P23’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where RPS29P23 RNA is repressed in tumor relative to normal tissue. In most cancer types RPS29P23 is over-expressed in tumor, although a few such as LUSC and THCA show the opposite, repressed pattern.

LUSC and THCA are the cancer types where RPS29P23 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS29P23 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	All	−0.152	.007	2	view →
THCA	All	II,III,IV	−0.123	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RPS29P23–LUSC

Open the LUSC breakdown →